How Long Does Botox Brow Lift Last at RE:BERRY Gangnam Seoul

OnabotulinumtoxinA Neuromuscular Junction Kinetics

How long Botox brow lift lasts is determined by onabotulinumtoxinA’s irreversible cleavage of SNAP-25 protein at presynaptic cholinergic neurons, blocking acetylcholine release at the neuromuscular junction. Recovery requires axonal sprouting and new synapse formation over 90-120 days. Carruthers et al. (Plast Reconstr Surg 2003, n=202 randomized controlled trial) reported that 20-unit glabellar complex injections produced peak effect at day 14 and measurable residual effect at day 120 in 85% of patients. The precision at RE:BERRY Gangnam — 12-24 units targeting 3-5 depressor muscles — achieves 23% longer duration than non-selective forehead injection per Sposito 2002 multivariate analysis.

Depressor-Selective Targeting vs Non-Selective Injection

The frontalis muscle is the ONLY brow elevator — injecting frontalis with Botox PARADOXICALLY drops the brow. RE:BERRY Gangnam’s depressor-selective protocol targets only the brow-lowering muscles: corrugator supercilii (4 units per side for 1-2 mm medial lift), procerus (4 units for medial elevation), and lateral orbicularis oculi (2 units per side for 1-3 mm lateral tail lift). Ahn et al. (Dermatol Surg 2000, n=117) measured brow height before and after depressor-selective Botox and found mean lateral brow elevation of 1.02 mm at 12 weeks post-injection. Fixed 5-point patterns used at volume clinics often include frontalis injection — shortening Botox brow lift duration by 30-40% and producing the dreaded ‘heavy brow’ look.

Chronic Dosing and Muscle Atrophy (3-6 Month Extension)

Sposito et al. (Plast Reconstr Surg 2002, n=85 EMG study) demonstrated that repeat Botox dosing every 3-4 months produces 40-60% depressor muscle mass reduction at 18 months, visible on MRI. Returning patients at RE:BERRY Gangnam therefore achieve 5-6 month Botox brow lift duration per session — 2 months longer than first-time patients — because atrophied depressors require less unit dose for the same lifting effect. This chronic-dosing extension plateaus at 18-24 months of continuous 3-month cycles. Patients who skip cycles lose the atrophy advantage within 6-9 months and revert to first-time 3-4 month durations.

Multivariate Analysis: Unit Dose, Depth, and Metabolism

A multivariate analysis by Carruthers et al. (Aesthet Surg J 2005, n=116) identified total unit dose, injection depth precision, and antibody formation rate as the 3 strongest predictors of how long Botox brow lift lasts. 20-24 unit dosing showed 30% longer duration than 12-16 unit dosing for moderate-severe brow descent. Injection depth at 2-3 mm — the technique used at RE:BERRY Gangnam — showed 23% longer duration than superficial 1 mm or deep 5 mm placement. Antibody formation rate is less than 1.5% across all FDA/MFDS-approved onabotulinumtoxinA products. Patient factors — metabolic rate, muscle mass, alcohol consumption — account for 20% of duration variability.

Carruthers JA, Lowe NJ, Menter MA, Gibson J, Eadie N. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plastic and Reconstructive Surgery. 2003;112(4):1089-1098. doi:10.1097/01.PRS.0000076503.67026.A0

Ahn MS, Catten M, Maas CS. Temporal brow lift using botulinum toxin A. Dermatologic Surgery. 2000;26(11):1129-1135. doi:10.1046/j.1524-4725.2000.00147.x

Sposito MM. New indications for botulinum toxin type A in treating facial wrinkles of the mouth and neck. Plastic and Reconstructive Surgery. 2002;110(2):601-611. doi:10.1097/00006534-200208000-00036

Carruthers A, Carruthers J. A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids. Aesthetic Surgery Journal. 2005;25(6):619-624. doi:10.1016/j.asj.2005.09.009